Technical Analysis for EVFM - Evofem Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Historical EVFM trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Reached Overbought | Strength | 0.00% | |
Weak + Overbought | Other | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
NR7 | Range Contraction | 4.43% | |
Calm After Storm | Range Contraction | 5.20% | |
Upper Bollinger Band Touch | Strength | 5.20% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 4.04% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 4.04% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
Upper Bollinger Band Resistance | about 19 hours ago | |
1.5x Volume Pace | about 20 hours ago | |
Up 3% | about 20 hours ago | |
Up 2% | about 20 hours ago | |
Rose Above Previous Day's High | about 20 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/09/2020
Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes women's sexual and reproductive health products. Its lead product candidate is Amphora, a non-hormonal woman-controlled vaginal gel, which is in Phase 3 clinical trial for the prevention of pregnancy; and in Phase 2b trial for the prevention of chlamydia and gonorrhea in women. The company is also developing multi-purpose vaginal pH regulator gel product candidate for the reduction of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Health Products Vagina Gynaecology Human Reproduction Sexually Transmitted Diseases And Infections Chlamydia Reproductive Health
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Health Products Vagina Gynaecology Human Reproduction Sexually Transmitted Diseases And Infections Chlamydia Reproductive Health
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.21 |
52 Week Low | 1.91 |
Average Volume | 2,655,789 |
200-Day Moving Average | 3.17 |
50-Day Moving Average | 2.37 |
20-Day Moving Average | 2.59 |
10-Day Moving Average | 2.71 |
Average True Range | 0.16 |
ADX | 43.07 |
+DI | 30.31 |
-DI | 7.90 |
Chandelier Exit (Long, 3 ATRs ) | 2.44 |
Chandelier Exit (Short, 3 ATRs ) | 2.54 |
Upper Bollinger Band | 2.87 |
Lower Bollinger Band | 2.31 |
Percent B (%b) | 0.93 |
BandWidth | 21.42 |
MACD Line | 0.12 |
MACD Signal Line | 0.10 |
MACD Histogram | 0.0193 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.09 | ||||
Resistance 3 (R3) | 3.09 | 3.00 | 3.04 | ||
Resistance 2 (R2) | 3.00 | 2.94 | 3.00 | 3.03 | |
Resistance 1 (R1) | 2.92 | 2.90 | 2.96 | 2.92 | 3.01 |
Pivot Point | 2.83 | 2.83 | 2.86 | 2.83 | 2.83 |
Support 1 (S1) | 2.75 | 2.77 | 2.79 | 2.75 | 2.65 |
Support 2 (S2) | 2.66 | 2.73 | 2.66 | 2.63 | |
Support 3 (S3) | 2.58 | 2.66 | 2.62 | ||
Support 4 (S4) | 2.58 |